跳至主要内容
临床试验/NCT01042093
NCT01042093已完成不适用

Efficacy of Multimodal Perioperative Analgesia Protocol With Periarticular Drug Injection in Total Knee Arthroplasty: A Randomized, Double Blind Study

Towson Orthopaedic Associates0 个研究点目标入组 160 人开始时间: 2010年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
160
主要终点
Numerical Rating Scale (NRS) Pain Scores During Hospitalization.

研究概览

简要总结

The purpose of this study is to compare different medication combinations used in a periarticular injection after total knee replacement surgery(TKR). A periarticular injection is an injection that is given into the tissues surrounding the knee joint. The injection is given while the patient is still in surgery.

The study will compare the level of pain management, length of hospital stay, range of motion and side effects from subjects receiving one of four different combinations of medication in a periarticular injection. The medications used in the injections are approved medications routinely used for pain management.

Approximately 160 subjects will participate in this study. The surgeon, study personnel, and patients will be blinded to the combination of medications each patient receives. The pharmacist will prepare the 4 different combinations of medications, randomize each patient to the particular combination of medications, and maintain the study drug documentation.

详细描述

Data Collection:

Data will be collected from the patient's pre-operative office visit, up to six weeks post-operatively.

Variables

Pre-operative Collection:

  • Vital signs
  • Hb/Hct
  • Age
  • Sex
  • BMI
  • WOMAC Score - Screen Failure at 36 or 12
  • Visual Analog Scale (VAS)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
30 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men and Women aged 30 to 85 years
  • Voluntary, written informed consent given to participate in this clinical investigation

排除标准

  • Pregnant or lactating women
  • Presence of allergies or contraindication to any medications indicated in the study
  • Contraindication to or failure of spinal anesthesia
  • Known drug or alcohol abuse or psychologic disorder that could affect follow-up care or treatment outcomes
  • Patients with a diagnosis of inflammatory arthritis
  • Previous major bone surgery in the operative knee
  • Simultaneous, bilateral TKRs

研究组 & 干预措施

ROP/EPI/TOR/CLO

Active Comparator

Ropivacaine 5mg/ml (49.25 ml) Epinephrine 1 mg/ml (0.5 ml) Toradol 30mg/ml (1 ml) Clonidine 0.1 mg/ml (0.08mg - 0.8 ml)

干预措施: Ropivacaine (Drug)

ROP/EPI/TOR/CLO

Active Comparator

Ropivacaine 5mg/ml (49.25 ml) Epinephrine 1 mg/ml (0.5 ml) Toradol 30mg/ml (1 ml) Clonidine 0.1 mg/ml (0.08mg - 0.8 ml)

干预措施: Epinephrine (Drug)

ROP/EPI/TOR/CLO

Active Comparator

Ropivacaine 5mg/ml (49.25 ml) Epinephrine 1 mg/ml (0.5 ml) Toradol 30mg/ml (1 ml) Clonidine 0.1 mg/ml (0.08mg - 0.8 ml)

干预措施: Toradol (Drug)

ROP/EPI/TOR/CLO

Active Comparator

Ropivacaine 5mg/ml (49.25 ml) Epinephrine 1 mg/ml (0.5 ml) Toradol 30mg/ml (1 ml) Clonidine 0.1 mg/ml (0.08mg - 0.8 ml)

干预措施: Clonidine (Drug)

ROP/EPI/TOR

Active Comparator

Ropivacaine 5mg/ml (49.25 ml) Epinephrine 1 mg/ml (0.5 ml) Toradol 30mg/ml (1 ml)

干预措施: Ropivacaine (Drug)

ROP/EPI

Active Comparator

Ropivacaine 5mg/ml (49.25ml) Epinephrine 1 mg/ml (0.5 ml)

干预措施: Ropivacaine (Drug)

ROP/EPI/TOR

Active Comparator

Ropivacaine 5mg/ml (49.25 ml) Epinephrine 1 mg/ml (0.5 ml) Toradol 30mg/ml (1 ml)

干预措施: Toradol (Drug)

ROP/EPI/TOR

Active Comparator

Ropivacaine 5mg/ml (49.25 ml) Epinephrine 1 mg/ml (0.5 ml) Toradol 30mg/ml (1 ml)

干预措施: Epinephrine (Drug)

ROP/EPI/CLO

Active Comparator

Ropivacaine 5mg/ml (49.25 ml) Epinephrine 1 mg/ml (0.5 ml) Clonidine 0.1 mg/ml (0.08mg - 0.8 ml)

干预措施: Ropivacaine (Drug)

ROP/EPI/CLO

Active Comparator

Ropivacaine 5mg/ml (49.25 ml) Epinephrine 1 mg/ml (0.5 ml) Clonidine 0.1 mg/ml (0.08mg - 0.8 ml)

干预措施: Clonidine (Drug)

ROP/EPI/CLO

Active Comparator

Ropivacaine 5mg/ml (49.25 ml) Epinephrine 1 mg/ml (0.5 ml) Clonidine 0.1 mg/ml (0.08mg - 0.8 ml)

干预措施: Epinephrine (Drug)

ROP/EPI

Active Comparator

Ropivacaine 5mg/ml (49.25ml) Epinephrine 1 mg/ml (0.5 ml)

干预措施: Epinephrine (Drug)

结局指标

主要结局

Numerical Rating Scale (NRS) Pain Scores During Hospitalization.

时间窗: 2 days after surgery

Patient pain was assessed during hospitalization using the VAS Pain Scale, a numerical rating scale ranging from 0 (no pain) to 10 (severe pain). A lower score represents a better outcome. Pain was assessed preoperatively, 1 hour postoperatively in the post anesthesia unit, and then every 8 hours on the Orthopedic inpatient unit, for a duration of 2 days.

次要结局

  • Narcotic Consumption During Hospitalization(4 days)
  • Knee Society Pain Scores at 6 Week Follow-up Appointment(6 weeks after surgery)

研究者

发起方
Towson Orthopaedic Associates
申办方类型
Other
责任方
Principal Investigator
主要研究者

David F. Dalury, MD

Orthopaedic Surgeon

Towson Orthopaedic Associates

相似试验